title: Analysis of Green Light Committee implementation and acquisition of second-line drug resistance.
authors.affiliation: Curry International Tuberculosis Center, Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital.
authors.forename: John Z
authors.initials: JZ
authors.lastname: Metcalfe
authors.affiliation: Department of Epidemiology and Biostatistics, University of California, San Francisco.
authors.forename: Eric
authors.initials: E
authors.lastname: Vittinghoff
authors.affiliation: Curry International Tuberculosis Center, Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital.
authors.forename: Philip C
authors.initials: PC
authors.lastname: Hopewell
mesh_terms: D000995:Antitubercular Agents / Q000627:therapeutic use*; D024901:Drug Resistance, Multiple, Bacterial; D005260:Female; D006801:Humans; D008297:Male; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy* / Q000382:microbiology*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000382:microbiology*
chemical_list: D000995:Antitubercular Agents